Literature DB >> 22541271

A patient with HIV infection presenting with diffuse membranous glomerulonephritis in a country with a low HIV prevalence--remarkable remission with therapy.

Selda Aydin1, Bilgül Mete, Mesut Yilmaz, Gulsah Yenidünya, Reşat Zaras, Aydın Tunckale, Fehmi Tabak.   

Abstract

The most common manifestation of HIV in the kidney is HIV-associated nephropathy (HIVAN). In this report, we describe the first documented case of membranous glomerulonephritis in an HIV-positive individual in Turkey, the country with the lowest HIV prevalence in the region. The case occurred in an HIV-positive, hepatitis C (HCV)-negative, and hepatitis B (HBV)-negative Caucasian male, who presented with nephrotic-range proteinuria. The patient had a favorable response to HAART and an angiotensin-receptor blocker.
Copyright © 2012 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22541271     DOI: 10.1016/j.jiph.2011.12.003

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  3 in total

Review 1.  A case of lupus-like glomerulonephritis in an HIV patient with nephrotic range proteinuria, purpura, and elevated IgA level.

Authors:  Jihyun Yang; Min Young Seo; Ki Tae Kim; Jun Yong Lee; Sun-Chul Kim; Myung-Gyu Kim; Sang-Kyung Jo; Won-Yong Cho; Hyoung-Kyu Kim; Nam Hee Won; Ran-Hui Cha; Eunjung Cho
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Membranous nephropathy in patients with HIV: a report of 11 cases.

Authors:  Vivek Charu; Nicole Andeen; Vighnesh Walavalkar; Jessica Lapasia; Jin-Yon Kim; Andrew Lin; Richard Sibley; John Higgins; Megan Troxell; Neeraja Kambham
Journal:  BMC Nephrol       Date:  2020-09-18       Impact factor: 2.388

3.  Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia A successfully managed with rituximab - case report and review of the literature.

Authors:  Nicholas Meyer; Wendy Cooper; Paul Kirwan; Roger Garsia; Scott Dunkley; David M Gracey
Journal:  BMC Nephrol       Date:  2021-07-22       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.